1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. Philip Morris International Acquires Vectura

M&A Deal Summary

Philip Morris International Acquires Vectura

On July 9, 2021, Philip Morris International acquired life science company Vectura for 852M GBP

Acquisition Highlights
  • This is Philip Morris International’s 2nd transaction in the Life Science sector.
  • This is Philip Morris International’s 2nd largest (disclosed) transaction.
  • This is Philip Morris International’s 2nd transaction in the United Kingdom.

M&A Deal Summary
Date 2021-07-09
Target Vectura
Sector Life Science
Buyer(s) Philip Morris International
Deal Type Add-on Acquisition
Deal Value 852M GBP

Target

Vectura

Chippenham, United Kingdom
Vectura is a provider of innovative inhaled drug delivery solutions that enable partners to bring their medicines to patients. The company has thirteen key inhaled and eleven non inhaled products marketed by major global pharmaceutical partners and a diverse portfolio of partnerships for drugs in clinical development. Vectura was founded in 1997 and is based in Chippenham, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Philip Morris International

Stamford, Connecticut, United States
Category Company
Founded 1987
Sector Consumer Products
Employees83,100
Revenue 37.9B USD (2024)
DESCRIPTION

Philip Morris International is a cigarette and tobacco company. Phillip Morris sells products in over 200 countries. Philip Morris International was founded in 1987 and is based in Stamford, Connecticut.

DEAL STATS #
Overall 5 of 8
Sector: Life Science M&A 2 of 3
Type: Add-on Acquisition M&A Deals 5 of 7
Country: United Kingdom M&A 2 of 2
Year: 2021 M&A 2 of 3
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-01 Fertin

Vejle, Denmark

Fertin develops and manufactures pharmaceutical and nutraceutical products for leading global companies to support healthier living. Fertin’s product portfolio has a broad variety of current and possible application areas including Nicotine Replacement Therapy, oral care, gastrointestinal, pain and allergy management, cough and cold, and much more. Fertin was founded in 1915 and is based in Vejle, Denmark.

Buy kr.5.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-09 Otitopic

Los Angeles, California, United States

OtiTopic is an innovative pharmaceutical start-up company that holds several key patents, differentiated intellectual property, and has confirmed a 505(b)2 pathway through constructive interactions with the FDA. OtiTopic was formed in 2012 and is based in Los Angeles, California.

Buy -
Mergr

Solution for

Product

Company

Legal